← Leaderboards
Mark C Hall
Purdue University
$2,231,223
Attributed
$2,231,223
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $854K · FY2023–25$1M$750K$500K$250K$0
'23
'24
'25
Funding mix
By agency
NIH$2,231,223 · 2
By mechanism
R01$1,807,856 · 1
R21$423,367 · 1
Top collaborators
No co-investigators on record.
Most similar at Purdue University
Same institution · by research overlap
- Scott D Briggs$3,444,237
- Shankar Thangamani$1,792,435
Others in their field
Other Rising Stars on “Multi-Drug Resistance”
- Andrew Tomaras · Forge Therapeutics, Inc.$4,712,500
- C.k. Osborne · Leidos Biomedical Research, Inc.$3,516,733
- Laurene Wang · Aimmax Therapeutics, Inc.$3,356,811
- Justin Blaine Schaal · University Of Southern California$3,025,760
- Paul Sebahar · Curza Inc$2,858,436
- Ajit K Parhi · Taxis Pharmaceuticals, Inc.$2,799,789
Research focus
Multi-Drug ResistanceMouse ModelExperimental StudyHospitalsInfectionMolecular TargetDrug ResistanceEvolutionFungi ModelFutureImmuneAnimalsInhibitorLifeDisease OutbreaksDrug DevelopmentDrug Resistant PathogenDrug TargetingCandida AlbicansC-TerminalAuxinsCandidiasisBenignMycoses
Grant awards (5)
Cdc14 phosphatase - novel roles in drug resistance, virulence, and the response to cell wall stress in fungal pathogens$592,582
R01 · FY2025 · AI · contact PI
Cdc14 phosphatase - novel roles in drug resistance, virulence, and the response to cell wall stress in fungal pathogens$592,582
R01 · FY2024 · AI · contact PI
Development and application of auxin-inducible degradation in Candida pathogens$192,017
R21 · FY2024 · AI · contact PI
Cdc14 phosphatase - novel roles in drug resistance, virulence, and the response to cell wall stress in fungal pathogens$622,692
R01 · FY2023 · AI · contact PI
Development and application of auxin-inducible degradation in Candida pathogens$231,350
R21 · FY2023 · AI · contact PI